Clincosm LogoSign in Get a demo

Primary Cesarean Section in Primigravida and Muligravida in Sohag and Al Balyana Cities

Sponsor
Sohag University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06083727
Collaborator
(none)
100
Enrollment
1
Location
6
Anticipated Duration (Months)
16.7
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

cesarean section and vaginal delivery are two methods of delivery, cesarean section somtimes indicated for obstetrical reason but primary cesarean section especially in primigravida might have a preference of the mode of delivery

Condition or Disease Intervention/Treatment Phase
  • Other: rate of cesarean section

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Primary Cesarean Section in Primigravida and Muligravida in Sohag and Al Balyana Cities
Actual Study Start Date :
Sep 24, 2023
Anticipated Primary Completion Date :
Mar 24, 2024
Anticipated Study Completion Date :
Mar 24, 2024

Arms and Interventions

Arm Intervention/Treatment
primigravida

Other: rate of cesarean section
rate of primary cesarean section in primigravida and multigravida
multigravida

Other: rate of cesarean section
rate of primary cesarean section in primigravida and multigravida

Outcome Measures

Primary Outcome Measures

  1. rate [6 months]

    rate of primary cesarean section

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Inclusion Criteria:

  • all primigravida with gestational age more than 28 weeks and above who have come for delivery

  • multigravida upto gravida 4 with gestational age more than 28 weeks and above who has had one previous viable vaginal delivery

  • women between 18 and 45 years

Exclusion Criteria:

  • primigravida women <28 weeks

  • multigravida <28 weeks

  • patient having previous history of myomectomy or hystrotomy

  • gravida 5 and more

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sohag university Sohag Egypt Sohag

Sponsors and Collaborators

  • Sohag University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sahar Nasser Fathy, resident at obstetric and gynacology department at sohag university hospial, Sohag University
ClinicalTrials.gov Identifier:
NCT06083727
Other Study ID Numbers:
  • Soh-Med-23-09-03MS
First Posted:
Oct 16, 2023
Last Update Posted:
Oct 16, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Oct 16, 2023